0.4471
-0.0729
(-14.02%)
At close: 4:00:02 PM EDT
0.4640
+0.02
+(3.78%)
After hours: 5:25:22 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-92,378
-92,378
-93,717
-44,765
-51,052
Investing Cash Flow
-119,242
-119,242
-4,464
-16,782
-2,796
Financing Cash Flow
111,307
111,307
236
41,509
242,685
End Cash Position
59,398
59,398
159,711
257,656
277,694
Income Tax Paid Supplemental Data
--
--
--
--
43
Capital Expenditure
-1,118
-1,118
-4,464
-16,782
-13,046
Issuance of Capital Stock
110,918
110,918
--
43,360
238,129
Free Cash Flow
-93,496
-93,496
-98,181
-61,547
-64,098
12/31/2021 - 1/26/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PASG Passage Bio, Inc.
0.3619
-11.52%
GOSS Gossamer Bio, Inc.
0.7770
-11.77%
DSGN Design Therapeutics, Inc.
2.7900
-5.90%
NKTX Nkarta, Inc.
1.5300
-2.55%
ELEV Elevation Oncology, Inc.
0.2700
+3.85%
ADVM Adverum Biotechnologies, Inc.
3.3300
-6.98%
RLYB Rallybio Corporation
0.2506
+0.24%
PMVP PMV Pharmaceuticals, Inc.
0.8700
-7.86%
INDP Indaptus Therapeutics, Inc.
0.4800
-5.33%
VTYX Ventyx Biosciences, Inc.
0.9281
-7.19%